Is COVID-19 a Risk Factor for Progression of Benign Prostatic Hyperplasia and Exacerbation of Its Related Symptoms?: A Systematic Review

    Abdolreza Haghpanah, Fatemeh Masjedi, Mehdi Salehipour, Alireza Hosseinpour, Jamshid Roozbeh, Akram Dehghani
    Image of study
    TLDR COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.
    The systematic review, which analyzed 52 papers, suggests that COVID-19 may exacerbate symptoms and progression of benign prostatic hyperplasia (BPH). The SARS-CoV-2 virus, which causes COVID-19, may infect the prostate gland by binding to angiotensin converting enzyme 2 (ACE2), leading to inflammation and metabolic disturbances. This process could worsen lower urinary tract symptoms (LUTS) and BPH. The review also highlights the potential role of androgens, noting that COVID-19 may be androgen-mediated and that males with androgenic alopecia could be at greater risk of severe COVID-19. The document suggests that 5-alpha reductase inhibitors, such as finasteride, may reduce COVID-19 symptoms. However, the review concludes that more research is needed to confirm whether COVID-19 is a risk factor for BPH progression and symptom exacerbation.
    Discuss this study in the Community →

    Research cited in this study

    9 / 9 results

    Related Community Posts Join

    6 / 295 results

      community My Progress - 56 y/o with NW7 hairloss

      in Progress Pictures  65 upvotes 3 years ago
      A 57-year-old man with severe hair loss since age 14 tried various hair loss treatments over two years, including finasteride, dutasteride, minoxidil, and supplements, with some minor regrowth. He also experimented with topical treatments and microneedling, but results were not cosmetically significant.

      community Goodbye tressless. I’ve decided to give in to my hairloss.

      in Update  594 upvotes 1 year ago
      Kitchen_Plastic_2847 had been fighting hair loss since 2019-2020 and was initially successful in regrowing his hair with finasteride. However, after contracting Covid three times back to back at the start of 2021, he started to lose his hair again. He found a new dermatologist who prescribed him oral minoxidil along with finasteride, but eventually decided it wasn't worth spending all the money to try and save his hair.

      community Adrogens and Covid-19

      in Treatment  7 upvotes 4 years ago
      The possible increased risk of severe Covid-19 cases in men due to higher androgen levels, and how taking medications such as finasteride, dutasteride, spironolactone, enzalutamide, or canabidiol might help mitigate the severity of the disease.

    Similar Research

    5 / 1000+ results